Zurich Cantonal Bank’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-467
| Closed | -$33.9K | – | 2803 |
|
2023
Q1 | $33.9K | Sell |
467
-72
| -13% | -$5.22K | ﹤0.01% | 2680 |
|
2022
Q4 | $44.2K | Buy |
539
+117
| +28% | +$9.59K | ﹤0.01% | 2635 |
|
2022
Q3 | $40K | Hold |
422
| – | – | ﹤0.01% | 2657 |
|
2022
Q2 | $82K | Sell |
422
-9
| -2% | -$1.75K | ﹤0.01% | 2369 |
|
2022
Q1 | $100K | Sell |
431
-31
| -7% | -$7.19K | ﹤0.01% | 2289 |
|
2021
Q4 | $182K | Sell |
462
-9
| -2% | -$3.55K | ﹤0.01% | 2125 |
|
2021
Q3 | $211K | Buy |
471
+1
| +0.2% | +$448 | ﹤0.01% | 1887 |
|
2021
Q2 | $183K | Buy |
470
+9
| +2% | +$3.5K | ﹤0.01% | 1861 |
|
2021
Q1 | $165K | Buy |
461
+22
| +5% | +$7.87K | ﹤0.01% | 1892 |
|
2020
Q4 | $215K | Sell |
439
-70
| -14% | -$34.3K | ﹤0.01% | 1799 |
|
2020
Q3 | $165K | Hold |
509
| – | – | ﹤0.01% | 1737 |
|
2020
Q2 | $185K | Buy |
509
+330
| +184% | +$120K | ﹤0.01% | 1566 |
|
2020
Q1 | $38K | Buy |
179
+71
| +66% | +$15.1K | ﹤0.01% | 2064 |
|
2019
Q4 | $44K | Hold |
108
| – | – | ﹤0.01% | 2209 |
|
2019
Q3 | $38K | Buy |
108
+40
| +59% | +$14.1K | ﹤0.01% | 2195 |
|
2019
Q2 | $34K | Hold |
68
| – | – | ﹤0.01% | 2268 |
|
2019
Q1 | $67K | Sell |
68
-16
| -19% | -$15.8K | ﹤0.01% | 1822 |
|
2018
Q4 | $73K | Hold |
84
| – | – | ﹤0.01% | 1789 |
|
2018
Q3 | $87K | Hold |
84
| – | – | ﹤0.01% | 1798 |
|
2018
Q2 | $77K | Hold |
84
| – | – | ﹤0.01% | 1822 |
|
2018
Q1 | $82K | Buy |
+84
| New | +$82K | ﹤0.01% | 1715 |
|
2017
Q2 | – | Sell |
-256
| Closed | -$132K | – | 2528 |
|
2017
Q1 | $132K | Buy |
+256
| New | +$132K | ﹤0.01% | 1172 |
|